AVDL
Avadel Pharmaceuticals
AVDL
AVDL
65 hedge funds and large institutions have $88.5M invested in Avadel Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-10
Holders Change %
-13.33%
% of All Funds
1.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
13
Reduced
23
Closed
15
Calls
$160K
Puts
$354K
Net Calls
-$194K
Net Calls Change
-$278K
Top Buyers
Top Sellers
1 |
Renaissance Technologies
New York
|
-$2.06M |
2 |
Millennium Management
New York
|
-$2.03M |
3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.66M |
4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$924K |
5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$830K |